Catheter-associated urinary tract infections (CAUTIs) are one of the most common nosocomial infections and if untreated can lead to serious complications including bacteremia and death. Enterococcus faecalis is a leading causative agent of CAUTI and its ability to adhere and persist within the host along with its multiple antibiotic resistances makes it difficult to prevent and treat. Furthermore, E. faecalis can form biofilm and grow despite a robust inflammatory response during CAUTI. The molecular details of how E. faecalis adheres, grows in the bladder, forms biofilm and the importance of biofilm in persistence in CAUTI are not well understood. This project will use a recently optimized model of E. faecalis CAUTI to understand how interactions between the E. faecalis Epb pilus and fibrinogen contribute to disease. Important questions to be addressed include a molecular analysis of how the EbpA subunit of the pilus binds to fibrinogen and the importance of this interaction to CAUTI. Mutants defective for biofilm formation in vitro are fully capable of forming biofilm in murine CAUTI, suggesting that standard biofilm models do not reproduce relevant in vivo conditions. This project will evaluate a new model of fibrinogen-supplemented urine biofilms to determine if genes required for biofilm in this model are also required for biofilm in murine CAUTI and will test the importance of biofilm in causing disease. Finally, we have data to suggest that an EbpA subunit-based vaccine protects against murine CAUTI and that immunized animals generate antibody that blocks EbpA-fibrinogen binding. The project will test the protective efficacy of various EbpA sub-domain and peptide vaccines in comparison to formulations that use other pilus sub- units. Combined with passive transfers of sera from immunized animals and characterization of antibody responses, it will be possible to specifically test whether the mechanism of protection depends on blocking EbpA-fibrinogen binding. The data generated by this project will provide significant new insights into the pathogenesis of CAUTI with direct application to the development of new modalities of therapy. .

Public Health Relevance

Up to 30% of short-term and up to 100% of long-term patients with urinary tract catheters will develop a catheter-associated urinary tract infection (CAUTI). One of the most common types of bacteria causing CAUTI is Enterococcus faecalis, which is difficult to treat because of its resistance to multiple antibiotics. This project will use a novel mouse model of CAUTI to determine how E. faecalis uses hair-like appendages known as pili to attach to catheters and how it grows on the catheter and on bladder tissue and how vaccines that incorporate pilus proteins provide protective immunity. This information can be used to develop new therapeutic agents to prevent CAUTI.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Bacterial Pathogenesis Study Section (BACP)
Program Officer
Huntley, Clayton C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Shen, Jiangchuan; Walsh, Brenna J C; Flores-Mireles, Ana Lidia et al. (2018) Hydrogen Sulfide Sensing through Reactive Sulfur Species (RSS) and Nitroxyl (HNO) in Enterococcus faecalis. ACS Chem Biol 13:1610-1620
Xu, Wei; Flores-Mireles, Ana L; Cusumano, Zachary T et al. (2017) Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection. NPJ Biofilms Microbiomes 3:28
Walker, Jennifer N; Flores-Mireles, Ana L; Pinkner, Chloe L et al. (2017) Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract. Proc Natl Acad Sci U S A 114:E8721-E8730
Flores-Mireles, Ana L; Walker, Jennifer N; Bauman, Tyler M et al. (2016) Fibrinogen Release and Deposition on Urinary Catheters Placed during Urological Procedures. J Urol 196:416-421
Flores-Mireles, Ana L; Walker, Jennifer N; Potretzke, Aaron et al. (2016) Antibody-Based Therapy for Enterococcal Catheter-Associated Urinary Tract Infections. MBio 7:
Hibbing, Michael E; Conover, Matt S; Hultgren, Scott J (2016) The unexplored relationship between urinary tract infections and the autonomic nervous system. Auton Neurosci 200:29-34
Conover, Matt S; Flores-Mireles, Ana L; Hibbing, Michael E et al. (2015) Establishment and Characterization of UTI and CAUTI in a Mouse Model. J Vis Exp :e52892
Flores-Mireles, Ana L; Walker, Jennifer N; Caparon, Michael et al. (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269-84
Flores-Mireles, Ana L; Pinkner, Jerome S; Caparon, Michael G et al. (2014) EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Sci Transl Med 6:254ra127